Proceedings of the IVth Biennial South African Lymphoma Study Group meeting Cape Town, October 2010

dc.contributor.authorJacobs P.
dc.date.accessioned2011-05-15T16:18:15Z
dc.date.available2011-05-15T16:18:15Z
dc.date.issued2011
dc.description.abstract[No abstract available]
dc.description.versionEditorial
dc.identifier.citationTransfusion and Apheresis Science
dc.identifier.citation44
dc.identifier.citation2
dc.identifier.issn14730502
dc.identifier.other10.1016/j.transci.2011.01.011
dc.identifier.urihttp://hdl.handle.net/10019.1/14576
dc.subjectmonoclonal antibody
dc.subjectmonoclonal antibody cd30
dc.subjectrituximab
dc.subjectunclassified drug
dc.subjectcancer immunotherapy
dc.subjectcancer radiotherapy
dc.subjecteditorial
dc.subjectHodgkin disease
dc.subjecthuman
dc.subjectlymphoma
dc.subjectSouth Africa
dc.titleProceedings of the IVth Biennial South African Lymphoma Study Group meeting Cape Town, October 2010
dc.typeEditorial
Files